Cite
Response of metastatic acral melanoma with exon 11 BRAF G469A mutation to BRAF/MEK inhibition.
MLA
Julius, Katharina, et al. “Response of Metastatic Acral Melanoma with Exon 11 BRAF G469A Mutation to BRAF/MEK Inhibition.” Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, vol. 20, no. 4, Apr. 2022, pp. 528–30. EBSCOhost, https://doi.org/10.1111/ddg.14737.
APA
Julius, K., Kromer, C., Schnabel, V., Vlahova, L., Kitz, J., Schön, M. P., Sahlmann, C.-O., & Kretschmer, L. (2022). Response of metastatic acral melanoma with exon 11 BRAF G469A mutation to BRAF/MEK inhibition. Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 20(4), 528–530. https://doi.org/10.1111/ddg.14737
Chicago
Julius, Katharina, Christian Kromer, Viktor Schnabel, Lyubomira Vlahova, Julia Kitz, Michael P Schön, Carsten-Oliver Sahlmann, and Lutz Kretschmer. 2022. “Response of Metastatic Acral Melanoma with Exon 11 BRAF G469A Mutation to BRAF/MEK Inhibition.” Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20 (4): 528–30. doi:10.1111/ddg.14737.